Quick Takeaways
- INMB - Inmune Bio, Inc. has 10 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 10 Insiders of Inmune Bio, Inc.
- Symbol
- INMB on Nasdaq
- Location
- Boca Raton, FL
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 13 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Inmune Bio, Inc. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Xencor Inc | 10%+ Owner | $13,104,454 | Mixed | 03 Sep 2021 | ||
| Raymond Joseph Tesi | President and CEO, Director, 10%+ Owner | $9,907,426 | Filing P/S | 05 Dec 2024 | ||
| James Kelly Ganjei | Director | Mixed | 01 Dec 2025 | |||
| Cory Randall Ellspermann | Cfo | Mixed | 01 Dec 2025 | |||
| Edgardo Baracchini Jr. | Director | Mixed | 14 May 2024 | |||
| David J. Moss | Chief Executive Officer, Director | Mixed | 01 Dec 2025 | |||
| Marcia Allen | Director | Mixed | 01 Dec 2025 | |||
| Timothy J. Schroeder | Director | Mixed | 01 Dec 2025 | |||
| Mark William Lowdell | Chief Scientific Officer | Mixed | 01 Dec 2025 | |||
| Scott Juda | Director | Mixed | 01 Dec 2025 |
Top shareholders of Inmune Bio, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Xencor Inc |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,885,533
|
$13,104,454 | — | 03 Sep 2021 | |
| Raymond Joseph Tesi |
3/4/5
|
President and CEO, Director, 10%+ Owner |
—
mixed-class rows
|
1,833,368
mixed-class rows
|
$9,907,426 | — | 05 Dec 2024 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
5.2%
|
1,454,400
|
$3,359,664 | $0 | 30 Jun 2025 | |
| CVI Investments, Inc. |
13D/G
|
— |
4.9%
|
1,396,279
|
$3,225,404 | -$239,596 | 30 Jun 2025 | |
| Praetorian PR LLC |
13D/G
|
Kupperman Harris |
3.4%
|
921,200
|
$2,127,972 | -$1,700,160 | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.3%
|
1,212,100
|
$1,890,877 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
957,846
|
$1,494,240 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
441,650
|
$689,170 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
347,259
|
$541,724 | — | 31 Dec 2025 | |
| Dauntless Investment Group, LLC |
13F
|
Company |
1.1%
|
304,922
|
$475,678 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.9%
|
250,910
|
$391,419 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.75%
|
210,678
|
$328,658 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
175,649
|
$274,012 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.44%
|
122,512
|
$191,120 | — | 31 Dec 2025 | |
| Westside Investment Management, Inc. |
13F
|
Company |
0.39%
|
108,950
|
$169,962 | — | 31 Dec 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.25%
|
68,865
|
$107,429 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.22%
|
60,803
|
$94,852 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.21%
|
58,521
|
$91,293 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.2%
|
56,477
|
$88,104 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
50,252
|
$78,393 | — | 31 Dec 2025 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
0.16%
|
45,000
|
$70,200 | — | 31 Dec 2025 | |
| Jain Global LLC |
13F
|
Company |
0.15%
|
42,051
|
$65,600 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.15%
|
41,365
|
$64,530 | — | 31 Dec 2025 | |
| Focus Partners Advisor Solutions, LLC |
13F
|
Company |
0.15%
|
41,097
|
$64,111 | — | 31 Dec 2025 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.14%
|
37,805
|
$58,976 | — | 31 Dec 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.11%
|
32,018
|
$49,949 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
27,527
|
$42,935 | — | 31 Dec 2025 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.09%
|
25,987
|
$40,540 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.09%
|
25,363
|
$39,566 | — | 31 Dec 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.09%
|
24,857
|
$38,777 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.08%
|
22,957
|
$35,813 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.08%
|
21,950
|
$34,242 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
20,519
|
$32,010 | — | 31 Dec 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.07%
|
20,388
|
$32,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
18,541
|
$28,925 | — | 31 Dec 2025 | |
| Quadrature Capital Ltd |
13F
|
Company |
0.06%
|
16,961
|
$26,459 | — | 31 Dec 2025 | |
| LMR Partners LLP |
13F
|
Company |
0.06%
|
16,600
|
$25,896 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.06%
|
16,518
|
$25,768 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.05%
|
14,097
|
$21,991 | — | 31 Dec 2025 | |
| CARY STREET PARTNERS FINANCIAL LLC |
13F
|
Company |
0.05%
|
13,917
|
$21,711 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.05%
|
13,298
|
$20,745 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
10,581
|
$16,507 | — | 31 Dec 2025 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.04%
|
10,368
|
$16,175 | — | 31 Dec 2025 | |
| Mariner, LLC |
13F
|
Company |
0.04%
|
10,250
|
$15,991 | — | 31 Dec 2025 | |
| DAVENPORT & Co LLC |
13F
|
Company |
0.04%
|
10,000
|
$15,600 | — | 31 Dec 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
9,967
|
$15,549 | — | 31 Dec 2025 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.03%
|
7,989
|
$12,462 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
6,923
|
$10,800 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.02%
|
6,601
|
$10,298 | — | 31 Dec 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
5,912
|
$9,223 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for Inmune Bio, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| David J. Moss | INMB | Option (right to buy) | Award | 750,000 | 750,000 | 01 Dec 2025 | Direct | |||
| Mark William Lowdell | INMB | Option (right to buy) | Award | 600,000 | 600,000 | 01 Dec 2025 | Direct | |||
| Cory Randall Ellspermann | INMB | Option (right to buy) | Award | 300,000 | 300,000 | 01 Dec 2025 | Direct | |||
| Timothy J. Schroeder | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| Scott Juda | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| James Kelly Ganjei | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| Marcia Allen | INMB | Option (right to buy) | Award | 150,000 | 150,000 | 01 Dec 2025 | Direct | |||
| Timothy J. Schroeder | INMB | Stock Option (right to buy) | Award | 366,000 | 108,000 | 18 Nov 2025 | Direct | |||
| Timothy J. Schroeder | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -366,000 | 0 | 18 Nov 2025 | Direct | ||
| David J. Moss | INMB | Stock Option (right to buy) | Award | 1,478,000 | 400,000 | 18 Nov 2025 | Direct | |||
| David J. Moss | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -1,478,000 | 0 | 18 Nov 2025 | Direct | ||
| Mark William Lowdell | INMB | Stock Option (right to buy) | Award | 924,000 | 400,000 | 18 Nov 2025 | Direct | |||
| Mark William Lowdell | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -924,000 | 0 | 18 Nov 2025 | Direct | ||
| Scott Juda | INMB | Stock Option (right to buy) | Award | 366,000 | 108,000 | 18 Nov 2025 | Direct | |||
| Scott Juda | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -366,000 | 0 | 18 Nov 2025 | Direct | ||
| James Kelly Ganjei | INMB | Stock Option (right to buy) | Award | 366,000 | 108,000 | 18 Nov 2025 | Direct | |||
| James Kelly Ganjei | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -366,000 | 0 | 18 Nov 2025 | Direct | ||
| Cory Randall Ellspermann | INMB | Stock Option (right to buy) | Award | 245,000 | 75,000 | 18 Nov 2025 | Direct | |||
| Cory Randall Ellspermann | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -245,000 | 0 | 18 Nov 2025 | Direct | ||
| Marcia Allen | INMB | Stock Option (right to buy) | Award | 258,000 | 108,000 | 18 Nov 2025 | Direct | |||
| Marcia Allen | INMB | Stock Option (right to buy) | Disposed to Issuer | -100% | -258,000 | 0 | 18 Nov 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.